ジャヌスキナーゼ活性化の秘密を解明する
Ross L Levine1, Stevan R Hubbard2
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
まとめ
ジャヌスキナーゼ (JAK) の全長構造が決定され,標的薬の開発のための新しい洞察を提供した. この構造情報は,より効果的なJAK阻害剤の治療法を設計する上で極めて重要です.
科学分野:
- 生物化学
- 構造生物学
- 薬理学について
背景:
- ジャヌスキナーゼ (JAKs) は,サイトカイン信号伝達経路に関与する重要な細胞内信号伝達酵素である.
- JAKのシグナル伝達の不調は,様々な自己免疫疾患,炎症性疾患,および癌に関連しています.
- JAKを小分子阻害剤で標的化することは,重要な治療戦略として浮上しています.
研究 の 目的:
- 特定のジャヌスキナーゼの全長構造を決定する.
- JAKの活性化と抑制を理解するための詳細な構造的基礎を提供する.
- 新しいJAK阻害剤の構造に基づく薬剤設計を容易にする.
主な方法:
- 3次元構造を解明するためにX線結晶学を用いた.
- バイオケミカルアッセイは,キナーゼ活性と阻害剤結合の特徴を示すために使用された.
- 構造的特徴と相互作用を分析するために計算モデリングが利用されました.
主要な成果:
- 全長ジャヌスキナーゼの完全な構造が解明され,重要な構成状態が明らかになった.
- 構造分析により,キナーゼ活性と基板相互作用にとって重要な特定の領域が特定されました.
- 薬剤設計の改善の可能性を強調した.
結論:
- 決定された全長ジャヌスキナーゼ構造は,薬の開発に前例のない原子レベルの詳細を提供します.
- この構造的な洞察は,より選択的で強力なJAK阻害剤の合理的な設計を可能にします.
- この発見は,JAK媒介性疾患を標的とした改善された治療戦略の道を開きます.
関連する概念動画
The JAK-STAT Signaling Pathway
9.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.4K
MAPK Signaling Cascades
6.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K
cAMP-dependent Protein Kinase Pathways
6.7K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K
Amplifying Signals via Enzymatic Cascade
11.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
11.0K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K


